<code id='A3BFC6DAB3'></code><style id='A3BFC6DAB3'></style>
    • <acronym id='A3BFC6DAB3'></acronym>
      <center id='A3BFC6DAB3'><center id='A3BFC6DAB3'><tfoot id='A3BFC6DAB3'></tfoot></center><abbr id='A3BFC6DAB3'><dir id='A3BFC6DAB3'><tfoot id='A3BFC6DAB3'></tfoot><noframes id='A3BFC6DAB3'>

    • <optgroup id='A3BFC6DAB3'><strike id='A3BFC6DAB3'><sup id='A3BFC6DAB3'></sup></strike><code id='A3BFC6DAB3'></code></optgroup>
        1. <b id='A3BFC6DAB3'><label id='A3BFC6DAB3'><select id='A3BFC6DAB3'><dt id='A3BFC6DAB3'><span id='A3BFC6DAB3'></span></dt></select></label></b><u id='A3BFC6DAB3'></u>
          <i id='A3BFC6DAB3'><strike id='A3BFC6DAB3'><tt id='A3BFC6DAB3'><pre id='A3BFC6DAB3'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:39162
          Photo illustration of a person holding smartphone with website of company Welsh, Carson Anderson and Stowe (WCAS) on screen with logo
          Physician groups backed by Welsh, Carson, Anderson & Stowe are looking to influence federal merger policy. Adobe

          Three large and growing physician groups backed by the private equity giant Welsh, Carson, Anderson & Stowe have hired a prominent lobbying firm to influence federal policy covering mergers and acquisitions.

          Over the past two weeks, United Musculoskeletal Partners, U.S. Anesthesia Partners, and U.S. Radiology Specialists each registered with Forbes Tate Partners, a lobbying shop founded by political insiders who used to work in President Bill Clinton’s administration.

          advertisement

          The doctor groups hired Forbes Tate to lobby on “issues related to health care consolidation,” according to federal lobbying disclosures. Each company and Welsh Carson did not respond to inquiries. Forbes Tate also did not respond.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Inflation cooled significantly in June, bringing price hikes close to normal levels
          Inflation cooled significantly in June, bringing price hikes close to normal levels

          1:39ProducepricesaredisplayedatagrocerystoreinBrooklyn,Feb.14,2023.XinhuaNewsAgencyviaGettyImagesCon

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Amylyx ALS drug failure raises questions and concerns

          Relyvrio,anALSdrugmadebyAmylyxPharmaceuticals,failedtobeatplaceboinakeyclinicaltrial.AmylyxPharmaceu